ArticleFrontiers in immunology2026
Development of a prognostic model based on nutritional and inflammatory indicators for predicting postoperative survival in esophageal cancer: a retrospective study.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Systemic inflammation, immunity, and nutritional status are integral to tumor biology, shaping the microenvironment and influencing esophageal cancer (EC) outcomes. Yet, their integration into pragmatic prognostic tools-and potential implications for immunotherapy stratification-remain limited. This retrospective study assessed the prognostic value of the inflammation-immunity-nutrition score (IINS) and red cell distribution width-to-lymphocyte ratio (RLR), indicators reflecting host immunity, systemic inflammation, and nutritional reserve, in EC patients. Methods: Clinical data from 660 EC patients who underwent radical surgery (2012-2018) were retrospectively analyzed and randomly assigned to training ( Results: IINS, RLR, and eight additional factors were independent prognostic variables. The nomogram showed good calibration and superior discrimination versus AJCC staging, with a higher C-index and AUC in both cohorts. DCA, IDI, and NRI confirmed greater net benefit and improved risk reclassification. Conclusions: This study proposes and internally validates a nomogram linking immune-nutritional surrogates with survival in EC. By reflecting systemic inflammation and host immunity, the model supports individualized risk stratification, perioperative optimization, and may inform patient selection for immunotherapy. External multicenter validation is warranted.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.